PAciFy Cough—a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive disease that leads to lung scarring. Cough is reported by 85% of patients with IPF and can be a distressing symptom with a significant impact on patients’ quality of life. There are no proven effective therapies for IPF-related cough....

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhe, Banya, Winston, Chaudhuri, Nazia, Jakupovic, Ira, Maher, Toby M., Patel, Brijesh, Spencer, Lisa G., Thillai, Muhunthan, West, Alex, Westoby, John, Wijsenbeek, Marlies, Smith, Jaclyn, Molyneaux, Philip L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889046/
https://www.ncbi.nlm.nih.gov/pubmed/35236391
http://dx.doi.org/10.1186/s13063-022-06068-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889046/
https://www.ncbi.nlm.nih.gov/pubmed/35236391
http://dx.doi.org/10.1186/s13063-022-06068-4

Ejemplares similares